BioBridge: Innovation to Start-Up
“BioBridge: Innovation to Start-up” -tapahtuman tavoitteena on inspiroida ja tuoda yhteen uransa alkuvaiheessa olevia tutkijoita sekä startup-perustajia, jotka ovat onnistuneesti muuttaneet tutkimusideoita yritystoiminnaksi. Tapahtuman kieli on englanti.
The upcoming event “BioBridge: Innovation to Start-up” aims to inspire and connect early-career scientists with start-up founders who have successfully translated research ideas into entrepreneurial ventures.
BioBridge event series started in 2025, organised by early career researchers of Postdocs in Flames and Turku Bioscience Centers ‘PhD–Postdoc board’ at University of Turku and Åbo Akademi University. This is the third instalment of the BioBridge events and the event is open to academics of all levels of University of Turku and Åbo Akademi University.
Confirmed Speakers
CEO Olli Huhtinen, Evogence
CEO & Co-founder Preethy Paul, ATB Antivirals
CEO & Co-founder Manu Tamminen, Genomill
CSO, Founder, Board Member Jukka Westermarck, Thestra
CSO & Founder Isabella Pönkkä, Pure Luminescence Technologies
CTO Zahra ”Elmira” Jahanshah Rad, SisuSemi and University of Turku
Collaboration Manager Antti Nuutinen, Entrepreneurial Hub Konttori, University of Turku
Process Manager John Holmberg and Co-founder & Coordinator Elias Savonlahti, Turku Startup Hub
Chief Innovation Advisor Jaana Rantanen, Business Finland
Professor of Practice Timo Veromaa, University of Turku
Head of Business Development Anne Marjamäki, Innovation Services, University of Turku
The event is supported by the InFLAMES Flagship, the Doctoral Programme in Immunology, ImmuDocs Doctoral Pilot Programme and the Health, Diagnostics and Drug Development multidisciplinary theme of the University of Turku.
